Shanghai Sci & Tech VC Amends ACM Research Filing

TL;DR

Shanghai Sci & Tech VC updated their ACM Research filing. Watch for changes.

AI Summary

Shanghai Science & Technology Venture Capital (Group) Co., Ltd. filed an amendment (No. 3) to its Schedule 13D on October 29, 2024, regarding its holdings in ACM Research, Inc. The filing indicates a change in the reporting person, with Wangyu Ge now listed alongside Shanghai Science & Technology Venture Capital (Group) Co., Ltd. The specific details of the change in beneficial ownership or the exact number of shares held are not detailed in this excerpt.

Why It Matters

This amendment signals a potential shift in the ownership structure or reporting strategy for ACM Research, Inc., which could influence investor perception and future corporate actions.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings can indicate significant changes in a major shareholder's intentions or holdings, warranting close attention.

Key Players & Entities

• Shanghai Science & Technology Venture Capital (Group) Co., Ltd. (company) — Reporting Person
• ACM Research, Inc. (company) — Subject Company
• Wangyu Ge (person) — Reporting Person

FAQ

Key Financial Figures

• $0.0001 — ssuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• e663980_sc13da-acm.htm (SC 13D/A) — 47KB
• 0001193805-24-001287.txt ( ) — 49KB

Identity and Background

Item 2 Identity and Background

(a) of the Schedule 13D is hereby amended and restated in its

Item 2(a) of the Schedule 13D is hereby amended and restated in its entirety as follows: This Statement is filed by Shanghai Science and Technology Venture Capital (Group) Co., Ltd. (“ SHSTVC ”), a limited liability company established under the laws of the People’s Republic of China (“ PRC ”), and Shanghai Pudong Innotek Capital Co., Ltd. (sometimes referred to as Shanghai Pudong Science and Technology Investment Group Co., Ltd.), a limited liability company established under the laws of the PRC (“ PDICC ” or “ PDSTVC ”), as a joint statement pursuant to Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”). Schedule A hereto sets forth information regarding persons referred in Instruction C to Schedule 13D (with respect to each Reporting Person, its “ Related Persons ”). Item 4. Purpose of Transaction.

of the Schedule 13D is hereby amended by

Item 4 of the Schedule 13D is hereby amended by adding the following: In accordance with the administrative order applicable to SHSTVC, SHSTVC transferred all of its equity interest in PDICC to a third party. In connection with such transfer, on October 25, 2024, SHSTVC and PDICC terminated the Coordination Agreement. Item 5. Interest in Securities of the Issuer. Items 5(a), (b), (c) and (e) of the Schedule 13D are hereby amended and restated in their entirety as follows: (a) (1) Shanghai Science and Technology Venture Capital (Group) Co., Ltd. Number of shares: 2,338,510 Percentage of shares: 4.1% (2) Shanghai Pudong Innotek Capital Co., Ltd. Number of shares: 3,358,728 Percentage of shares: 5.8% The percentage of Class A Common Stock beneficially owned by the Reporting Persons reflects 57,449,013 shares of Class A Common Stock outstanding as set forth in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024. (b) (1) Shanghai Science and Technology Venture Capital (Group) Co., Ltd. Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 2,338,510 Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 2,338,510 (2) Shanghai Pudong Innotek Capital Co., Ltd. Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 3,358,728 Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 3,358,728 (c) Except as set forth in Exhibit 2 to the Schedule 13D (previously filed with Amendment No. 2 to the Schedule 13D), no Reporting Person has effected any transactions in the Common Stock during the past 60 days. (e) As of October 25, 2024 (New York City time), SHSTVC and PDICC terminated the Coordination Agreement and, accordingly, are no longer members of a “group” for purposes of Rule 13d-3 under the Securities Exchange Act of 193

of the Schedule 13D is hereby amended by

Item 6 of the Schedule 13D is hereby amended by adding the following: On October 25, 2024 (New York City time), SHSTVC and PDICC terminated the Coordination Agreement. SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: October 29, 2024 SHANGHAI SCIENCE AND TECHNOLOGY VENTURE CAPITAL (GROUP) CO., LTD. By: /s/ Wangyu Ge Name: Wangyu Ge Title: Authorized Representative SHANGHAI PUDONG INNOTEK CAPITAL CO., LTD. By: /s/ Lufei Liu Name: Lufei Liu Title: Authorized Representative

View Full Filing

View this SC 13D/A filing on SEC EDGAR